Skip to content
★ Sign in to follow
Keeps Biopharma Inc. logo

Keeps Biopharma Inc. Stock: price and insider trades · South Korea

킵스파마

KR·Mcap ₩111.8BFood & Beverage

No insider purchase over the last 90 days. The latest, by 김형규, was filed 03 Mar 2026.

Insider Decl.
26
Thresholds
n/a
Buy Volume
€51M
11 ops. · all time
Sell Volume
€4M
4 ops. · all time

Who traded when

BuySale
김정호1 sale
김형규1 buy
둠밈1 sale
한국투자파트너스1 buy

Since the insiders bought

  • Filed 03 Mar 2026 · 251 days ago · €14k
    -15.0%
    Entry ₩6,600 · Close 22 Oct 2026 ₩5,610
  • Filed 05 Nov 2024 · 734 days ago · €80k
    +87.2%
    Entry ₩5,160 · Close at T+365 ₩9,660
  • Filed 31 Aug 2021 · 1896 days ago · €7.5M
    -64.7%
    Entry ₩13,500 · Close at T+365 ₩4,770

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Fundamental score
Ranked 25,625 of 26,913 companies
15.2
score / 100
Value
9
Quality
21
FCF yld-55%
Earn yld-11%
EV/EBITDA·
ROE-16%
Gross mgn22%
Net mgn-5.8%
Debt/EBITDA·
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

₩5,570
Analyst consensus
·
Income statement
Revenue₩170.1B
Gross profit₩37.6B22% margin
EBITDA-₩49.7M-0% margin
Net income-₩9.8B-5.6% margin
Valuation
Beta1.00
Balance sheet & cash
Market cap₩111.8B
Total debt₩92.6B
Free Cash Flow-₩49.8B
Debt / Equity120%
Profitability & ownership
ROE-15.6%
ROA-0.2%
% insiders22.8%
% institutions0.7%
Last declaration on 14 May 2026
Declarations29 total
  • Other
    Other(filed)
    0DART
  • Other
    Other(filed)
    0DART
  • Other
    Other(filed)
    0DART
  • ▼
    Executives
    €940kest.0DART
    248,385 sharesKRXDART:20260514001028
  • ▼
    사장Executives
    €1.1Mest.0DART
    248,385 sharesShareKRXDART:20260514001086
  • ●
    Executives
    Executives(filed)
    0DART
  • ●
    Executives
    Executives(filed)
    0DART
  • ▲
    이사Executives
    €14kest.0DART
    3,006 sharesShareKRXDART:20260303002222
    Canonical exit: 30 May 2026 (T+90)
  • ●
    Executives
    Executives
    0DART
  • ▲
    Related company / holdingExecutives
    €8.0Mest.0DART
    761,622 sharesKRXDART:20250710000596
    Canonical exit: 15 Sept 2025 (T+90)
  • ▲
    상무Executives(filed)
    €80kest.0DART
    19,836 sharesShareKRXDART:20241105000262
    Canonical exit: 3 Feb 2025 (T+90)
  • ●
    Executives
    Executives(filed)
    0DART
  • ▲
    Related company / holdingExecutives
    €3.1Mest.0DART
    761,622 sharesKRXDART:20231213000394
    Canonical exit: 10 Mar 2024 (T+90)
  • ▲
    Related company / holdingExecutives
    €4.0Mest.0DART
    761,622 sharesKRXDART:20230913000359
    Canonical exit: 10 Dec 2023 (T+90)
  • ▲
    Related company / holdingExecutives
    €6.3Mest.0DART
    761,622 sharesKRXDART:20230616000474
    Canonical exit: 10 Sept 2023 (T+90)
  • ●
    상무Executives
    0DART
    ShareKRXDART:20230526000558
  • ▲
    Related company / holdingExecutives(filed)
    €5.6Mest.0DART
    761,622 sharesKRXDART:20230315000902
    Canonical exit: 13 Jun 2023 (T+90)
  • ●
    Executives
    Executives(filed)
    0DART
  • ●
    Executives
    Executives(filed)
    0DART
  • ▲
    Related company / holdingExecutives(filed)
    €3.8Mest.0DART
    761,622 sharesKRXDART:20221215000298
    Canonical exit: 15 Mar 2023 (T+90)
  • ▲
    Related company / holdingExecutives(filed)
    €3.2Mest.0DART
    761,622 sharesKRXDART:20220915000380
    Canonical exit: 14 Dec 2022 (T+90)
  • ▼
    Executives(filed)
    €1.7Mest.0DART
    275,811 sharesKRXDART:20220401001390
  • ▼
    Executives(filed)
    €377kest.0DART
    62,507 sharesKRXDART:20220329000313
  • ●
    Executives
    Executives(filed)
    0DART
  • ●
    Executives
    Executives(filed)
    0DART

25 of 29 declarations

About Keeps Biopharma Inc.

Nine of the 26 filings at Keeps Biopharma Inc. (킵스파마) come from a single large holder, 한국투자파트너스 (대량보유자), and every one is a purchase. This Korean company on the Korea Exchange, classed under Food & Beverage, is valued at KRW 111.8 billion, and insiders and declared holders own 22.8% of it.

Open-market trades come to 11 purchases and 4 sales, or 73% purchases, with no amount stored. 킵스파마 itself filed 8 times, 둠밈 filed 3 times including 2 sales, 최정주 (상무) filed twice including one purchase, and 김정호 (사장, president) made one sale. Eleven filings are neither purchases nor sales.

Read moreShow less

The 26 filings were published from March 15, 2021 to May 14, 2026, for trades dated from May 23, 2023 to May 7, 2026. The years 2022 and 2023 hold 7 each, 2025 only 1 and 2026 already 6. Over twelve months: 6 filings, 1 purchase and 2 sales. All filings together: median delay of 4 days.